Recombinant EGFR (Zalutumumab Biosimilar) 抗体
This Mammalian Cells 单克隆 anti-EGFR (Zalutumumab Biosimilar) antibody specifically detects EGFR (Zalutumumab Biosimilar) in ELISA. The antibody is reactive with 人 samples.
产品编号 ABIN7487875
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant EGFR (Zalutumumab Biosimilar) 抗体 (ABIN7487875)
抗原
EGFR (Zalutumumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This EGFR (Zalutumumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Zalutumumab Biosimilar - Anti-EGFR mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- EGFR (Zalutumumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
HuMax-EGFr
Zalutumumab (proposed trade name HuMax-EGFR) is a high affinity, completely human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR, also known as ErbB1/HER1). It is developed by Genmab and designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. Zalutumumab is derived from transgenic mice immunized with A431-derived EGFR. -
CAS-编号
- 667901-13-5
抗原
-
You are here:
